Satellos Bioscience MSLE
NASDAQ MSLE
$8.40 -0.11 (-1.28%)
As of: Oct 2, 2026 · 2:09 PM EDT

Satellos Bioscience (MSLE) Profit After Tax (2024 - 2026)

Updated

Satellos Bioscience (MSLE) recorded Profit After Tax of -$11.63 million in the quarter ended Jun 30, 2026, compared with -$5.54 million a year earlier.

Analysis

Satellos Bioscience (MSLE) Profit After Tax (2024 - 2026) Analysis & Trends

On a TTM basis, Satellos Bioscience's Profit After Tax came in at -$51.41 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it was -$24.53 million.

  • Across earlier years, Profit After Tax came in at -$18.92 million in the year ended Dec 31, 2024.
  • Quarterly Profit After Tax has ranged from -$24.53 million in the quarter ended Dec 31, 2025 to $6.08 million in the quarter ended Mar 31, 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.28 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -246.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Satellos Bioscience 131.40 Mn 131.40 Mn - -11.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.63 Mn
Mar 31, 2026 -9.70 Mn
Dec 31, 2025 -24.53 Mn
Jun 30, 2025 -5.54 Mn
Mar 31, 2025 6.08 Mn
Dec 31, 2024 -20.63 Mn
API Access

Satellos Bioscience Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=MSLE&period=max&api_key=YOUR_API_KEY